- Home
- Life Sciences
- Pharmaceutical
- Drug and Medication
- Drug and Medication Analysis & Statistics in the United Kingdom, January 2013 (p3)
Talk to Geoffrey
+1 718 618 4302
Search inside this page
Publication dates
Publishers
- Global Data (40)
- Global Research & Data Services (7)
- Business Monitor International (33)
- Datamonitor (18)
- VacZine Analytics Group Of Assay Advantage Ltd (9)
-
- Euromonitor International (5)
- Global Markets Direct (3)
- SCRIP Insights (3)
- GBI Research (2)
- Global Industry Analyst (2)
- Visiongain (2)
- Barnes Reports (1)
- BioPharm Reports (1)
- Daedal Research (1)
- DrugPatentWatch - ThinkBiotech LLC (1)
- Espicom Business Intelligence (1)
- Firstword Pharma (1)
- Freedonia (1)
- Ken Research Private (1)
- Key Note Publications Ltd (1)
- Koncept Analytics (1)
- La Merie Publishing (1)
- Marketest (1)
- Urch Publishing (1)
data types
Free Market Research Guides to Download
Drug and Medication Analysis & Statistics in the United Kingdom, January 2013 (p3)
You might be interested in: drug, vaccine, insulin, more »
» Purchase Premium Reports
61-100 of about 100 reports
United Kingdom Pharmaceutical Sales, % Of Gdp
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI
- Industries : Drug and Medication
- Countries : United Kingdom
United Kingdom Vaccine Exports, Us$mn, % Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : United Kingdom
United Kingdom Vaccine Exports, Gbpmn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : United Kingdom
United Kingdom Vaccine Exports, Gbpmn, % Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : United Kingdom
United Kingdom Pharmaceutical Sales, Us$ Per Capita
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI
- Industries : Drug and Medication
- Countries : United Kingdom
United Kingdom Pharmaceutical Sales At Constant Exchange Rate, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI
- Industries : Drug and Medication
- Countries : United Kingdom
United Kingdom Pharmaceutical Sales, Us$bn, % Chg Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI
- Industries : Drug and Medication
- Countries : United Kingdom
United Kingdom Pharmaceutical Sales, Gbpbn
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI
- Industries : Drug and Medication
- Countries : United Kingdom
United Kingdom Pharmaceutical Sales, Gbpbn, % Chg Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2005 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI
- Industries : Drug and Medication
- Countries : United Kingdom
United Kingdom Pharmaceutical Sales, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI
- Industries : Drug and Medication
- Countries : United Kingdom
Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020 Summary GlobalData's pharmaceuticals report, ?Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020? provides ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020 Summary GlobalData's pharmaceuticals report, ?Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020? provides Macitentan ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020 Summary GlobalData's pharmaceuticals report, ?Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020? provides ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020 Summary GlobalData's pharmaceuticals report, ?Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020? provides Veletri sales ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020 Summary GlobalData's pharmaceuticals report, ?Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020? provides Adcirca sales estimates ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020 Summary GlobalData's pharmaceuticals report, ?Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020? provides Revatio sales estimates ...
- Industries : Drug and Medication
- Countries : Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017
- $ 2 000
- Industry report
- October 2011
- by Global Data
Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017 Summary GlobalData's pharmaceuticals report, ?Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017? provides Ventavis sales estimates ...
- Industries : Drug and Medication
- Countries : World, United States, Spain, Italy, France, Germany, Europe, United Kingdom, Japan
Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020 Summary GlobalData's pharmaceuticals report, ?Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020? provides Tracleer sales estimates ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Gleevec - Analysis and Forecasts from 2013 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Gleevec - Analysis and Forecasts from 2013 to 2020 Summary GlobalData's pharmaceuticals report, ?Gleevec - Analysis and Forecasts from 2013 to 2020? provides Gleevec sales estimates for US, EU5 and Japan. ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Remodulin - Analysis and Forecasts from 2002 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Remodulin - Analysis and Forecasts from 2002 to 2020 Summary GlobalData's pharmaceuticals report, ?Remodulin - Analysis and Forecasts from 2002 to 2020? provides Remodulin sales estimates for US, EU5 and ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Riociguat - Analysis and Forecasts from 2013 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Riociguat - Analysis and Forecasts from 2013 to 2020 Summary GlobalData's pharmaceuticals report, ?Riociguat - Analysis and Forecasts from 2013 to 2020? provides Riociguat sales estimates for US, EU5 and ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Pharmaceuticals - United Kingdom
- $ 652
- Industry report
- September 2011
- by Global Research & Data Services
This market analysis gives an overview of the actual situation, trends and future outlook of the pharmaceutical market in the United Kingdom. The market analysis provides essential market information fo ...
- Industries : Drug and Medication
- Countries : United Kingdom
World Drug and Medication: Alcohol Addiction - Pipeline Review, H2 2011
- $ 500
- Industry report
- August 2011
- by Global Markets Direct
This report provides information on the therapeutic development for Alcohol Addiction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Drug and Medication
- Countries : World, United Kingdom
United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 3 2011
- $ 1 088
- Industry report
- July 2011
- by Business Monitor International
BMI View: The UK faces its most uncertain period in a generation, as the Conservative-Liberal Democrat coalition presses ahead with fiscal cutbacks and constitutional reform. Plans to modernise the National ...
- Industries : Drug and Medication
- Countries : United Kingdom
Excipients Market
- $ 4 800
- Industry report
- May 2011
- by Freedonia
US demand to approach $2 billion in 2015 US demand for pharmaceutical excipients is expected to approach $2 billion in 2015, driven by growing production of pharmaceuticals in the US and the increasing ...
- Industries : Drug and Medication
- Countries : United States, United Kingdom
Analgesics Industry Overview in the UK to 2014 (OTC Healthcare)
- $ 350
- Industry report
- March 2011
- by Datamonitor
his market research report also provides data on key supply chain and reveals the main industry players in the UK analgesics industry . Features and Benefits ? Identify key industry sectors by analyzing ...
- Industries : Drug and Medication
- Countries : United Kingdom
Cough and Cold Preparations Industry Overview in the UK to 2014 (OTC Healthcare)
- $ 350
- Industry report
- March 2011
- by Datamonitor
his market research report also provides data on key supply chain and reveals the main industry players in the UK cough and cold preparations industry . Features and Benefits ? Identify key industry sectors ...
- Industries : Drug and Medication
- Countries : United Kingdom
Antibacterials: Statistics and Forecast
- $ 15 200
- Industry report
- February 2011
- by Datamonitor
About This Report Over the next decade, the fragmented antibacterials industry will shift away from a blockbuster-business model, as generic erosion of industry leaders and increased competition between ...
- Industries : Drug and Medication
- Countries : Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom
United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 1 2011
- $ 1 088
- Industry report
- January 2011
- by Business Monitor International
The UK is ranked second among the 10 Western European industry s surveyed in BMI's Business Environment Ratings (BERs) for Q111, moving up from fifth position in the previous quarter. However, while it ...
- Industries : Drug and Medication
- Countries : United Kingdom
Neuropathic Pain Statistics and Forecast
- $ 15 200
- Industry report
- January 2011
- by Datamonitor
About This Report At present, only six drugs are indicated for the treatment of neuropathic pain. In 2010, two significant events impacted the neuropathic pain industry : the launch of Qutenza (8% capsaicin ...
- Industries : Drug and Medication
- Countries : United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
MarketVIEW: Pseudomonas aeruginosa vaccines
- $ 7 995
- Industry report
- January 2011
- by VacZine Analytics Group Of Assay Advantage Ltd
Gram-positive Pseudomonas aeruginosa (PA) is primarily a nosocomial pathogen accounting for around 10% of all hospital acquired infections second only toStaphylococcus aureus . PA infections are invasive ...
- Industries : Drug and Medication
- Countries : United States, Australia, Canada, United Kingdom, Spain, Italy, France, Germany, Japan, Europe
Drug and Medication in United Kingdom: Alcoholism - Pipeline Review, Q4 2010
- $ 500
- Company report
- December 2010
- by Global Markets Direct
This report provides data on the therapeutic development for Alcoholism , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Drug and Medication
- Countries : World, United Kingdom, Ireland, Japan
2011 Worldwide Pharmaceutical Preparation Mfg. Industry Report
- $ 249
- Industry report
- December 2010
- by Barnes Reports
The Pharmaceutical Preparation Mfg. Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2011 current ...
- Industries : Drug and Medication
- Countries : World, Argentina, Brazil, Mexico, Canada, Russian Federation, Italy, France, Germany, South Korea, Japan, India, China, Europe, United Kingdom, South America, Africa, Asia, North America
Biopharmaceutical in United States: Pipeline and Commercial Insight: Pneumococcal and Meningococcal Vaccines
- $ 15 200
- Industry report
- October 2010
- by Datamonitor
About This Report Over the next decade, Pfizer's Prevnar 13 is set to dominate the pneumococcal vaccine industry with sales that could reach USD 3.4 billion in infants and adults across the US and 5EU ...
- Industries : Drug and Medication
- Countries : United States, Europe, Japan, Spain, Italy, France, Germany, World, United Kingdom
New Approaches to Gaining Market Access for Pharmaceuticals: Pricing & Reimbursement, Policy Development, and the Role of HTAs
- $ 3 835
- Industry report
- October 2010
- by SCRIP Insights
Pharmaceutical costs are in the front line for containing healthcare costs as payors seek to manage constrained budgets while also meeting the healthcare demands of ageing patient populations. Market access ...
- Industries : Drug and Medication, Pharmaceutical
- Countries : Italy, United Kingdom, Europe, France, Japan, United States, Spain, Germany, World, Australia, Canada
New Approaches to Gaining Market Access for Pharmaceuticals
- $ 3 835
- Industry report
- September 2010
- by SCRIP Insights
Pharmaceutical costs are in the front line for containing healthcare costs as payors seek to manage constrained budgets while also meeting the healthcare demands of ageing patient populations. Market access ...
- Industries : Drug and Medication
- Countries : Italy, United Kingdom, Europe, France, Japan, United States, Spain, Germany, World, Australia, Canada
Drug and Medication in United States: Influenza Vaccines
- $ 2 000
- Industry report
- September 2010
- by Global Data
The report is an essential source of information and analysis on the global Influenza Vaccines industry . The report identifies the major industry developments shaping and driving the global Influenza ...
- Industries : Drug and Medication, Pharmaceutical, Biotechnology
- Countries : World, United States, United Kingdom
Pathology: Atopic Dermatitis
- $ 2 000
- Company report
- September 2010
- by Global Data
GlobalData has released its pharmaceutical report, ??. The report is an essential source of information and analysis on the global Atopic Dermatitis therapeutics industry . The report identifies the majo ...
- Industries : Therapy, Pathology, Drug and Medication
- Countries : World, United States, United Kingdom
Pathology: Urinary Incontinence
- $ 2 000
- Company report
- August 2010
- by Global Data
GlobalData, the market analysis specialist, has released its new report, ?? is an essential source of information and analysis on the Urinary Incontinence (UI) therapeutics industry . The report identifies ...
- Industries : Pathology, Drug and Medication
- Countries : World, United States, United Kingdom
Drug and Medication: Women's Infertility
- $ 2 000
- Company report
- August 2010
- by Global Data
GlobalData, the market analysis specialist, has released its new report, ?Women's Infertility - Pipeline Assessment and Industry Projections to 2017?. The report is an essential source of information ...
- Industries : Therapy, Pathology, Drug and Medication
- Countries : World, United States, United Kingdom
» Download Public Reports
About 200 reports
The United Kingdom: Country Brief, 2013-2014, focus on Medicine
- Country report
- February 2013
- 2 pages
... This pragmatic approach would, we believe, ensure the supply of medicines for patients up and down the uk, at a critical time. Speaking at the bapw spring business day in birmingham, mr sawer ...
Medicine Market In The United Kingdom
October 2012Medicine Market In The United Kingdom
October 2012Medicine Sector In The United Kingdom
November 2012The British Medicine Sector Brief
October 2012» Read our Company Profiles
2 CompaniesGlaxoSmithKline P.L.C.
United StatesGlaxoSmithKline PLC
United KingdomReportlinker.com © Copyright 2013. All rights reserved.
